Assessing the Effectiveness of Diabetes Interactive Diary (DID) in Diabetes Management

NCT ID: NCT00482443

Last Updated: 2008-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-03-31

Study Completion Date

2008-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For people with Type 1 Diabetes, blood glucose control is achieved by matching insulin doses directly to the amount of carbohydrate consumed. We are looking at new ways to help our patients with type 1 diabetes manage their diabetes control more effectively. We are testing if "Diabetes Interactive Diary" (DID), a novel programme designed to be used on a mobile phone, can represent an important tool in carbohydrate counting while avoiding the use of complex calculations and in depth knowledge about the carbohydrate content of their food.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is randomized control trial aimed to evaluate the effectiveness of a DID compare to the standard education approach in order to help the patients with Type 1 diabetes to estimate the carbohydrate in their food and adjust insulin doses. It involves individuals with Type 1 diabetes who are not habitually using carbohydrate counting. They should be testing their blood sugar levels at least 3 times a day, using multiple daily injections of short-acting and long-acting insulin analogues, with HbA1c between 7.5% and 10% and are familiar with the use of mobile phones and possess a personal SIM card.

Patients will be randomized to the standard education programme run for 4 full days over a 4 week period or to the DID programme run as three 2-hour sessions over a two-week period.

The DID is a novel software programme installed on the patient's mobile telephone. It facilitates the communication between the dietitian and the patient by using SMS text messages, so that the dietitian can monitor glycaemic control and suggest adjustments if necessary. It can be described as a little computer, where the patient can record their blood glucose value, the amount of insulin injected and the amount of carbohydrate consumed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

To assess the efficacy of a Diabetes Interactive Diary in Diabetes Management.

Group Type EXPERIMENTAL

A software programme in mobile telephone

Intervention Type OTHER

Use of Mobile phone technology in maintaining Diabetes Interactive Diary.

2

Control Arm. Patients will receive standard education programme.

Group Type ACTIVE_COMPARATOR

Standard Education Programme.

Intervention Type OTHER

Control Arm patients will receive a standard education programme designed to help the Type 1 Diabetic manage their condition.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A software programme in mobile telephone

Use of Mobile phone technology in maintaining Diabetes Interactive Diary.

Intervention Type OTHER

Standard Education Programme.

Control Arm patients will receive a standard education programme designed to help the Type 1 Diabetic manage their condition.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 or over
* Not habitually using carbohydrate counting and insulin dose adjustment
* Testing their blood sugar levels at least 3 times a day
* Using multiple daily injections of short-acting and long-acting insulin analogues
* With HbA1c between 7.5% and 10%
* Familiar with the use of mobile phones and possess a personal SIM card.

Exclusion Criteria

* Mental conditions, depression or high anxiety rendering the subject unable to understand the nature, scope, and possible consequences of the study
* Eating disorders
* Pregnancy
* Any clinically significant major organ system disease or infective diseases
* Any disease or condition or abuse of illicit drugs, prescription medicines or alcohol that in the opinion of the investigator may interfere with the completion of the study
* Subject unlikely to comply with protocol, e.g., uncooperative attitude, inability to return for follow-up visits and unlikely to complete the study procedures
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Royal Bournemouth Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Royal Bournemouth Hospital.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Kerr, Doctor

Role: PRINCIPAL_INVESTIGATOR

Royal Bournemouth Hospital

Anita Bowes, Dietitian

Role: PRINCIPAL_INVESTIGATOR

Royal Bournemouth Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Bournemouth Hospital

Bournemouth, Dorset, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DID

Identifier Type: -

Identifier Source: org_study_id